Health Press Release – Newsletter for November 25, 2010

HOYA Discusses the Future of Progressive Lenses on a Global Level

UITHOORN, Netherlands, November 24, 2010 – From 27 September until 1 October HOYA Vision Care invited a selection of
its best lens experts and VIP customers from all over the world to join its
Global PAL Summit in La Toja, Spain. Goal was to discuss in depth new
technological developments and share vision and plans on the [..] Read the original article: here.

HOYA Faculty Education & Experience Centre Officially Opens its Doors

BUDAPEST, Hungary, November 24, 2010 – On Tuesday evening November 9th around 110 invitees witnessed the opening
ceremony of HOYA's new Faculty Education and Experience Centre in the heart
of Budapest.

Amongst the guests were Japanese Ambassador to Hungary Mr. Tecuo Ito and
deputy Mayor of the Fifth District of Budapest Mr. Andras Puskas.
… Original article on : HOYA Faculty Education & Experience Centre Officially Opens its Doors.

Elsevier Announces the 9th Pangborn Sensory Science Symposium

OXFORD, England, November 24, 2010 – Elsevier, the leading publisher of scientific,
technical and medical information products and services, today announced that
the 9th Pangborn Sensory Science Symposium (www.pangborn2011.com/ )
has been confirmed, taking place in Kyoto, Japan on 4-8 September 2011.

With the last symposium attracting 1000 delegates, Pangborn is the most
prestigious conference … Read : Elsevier Announces the 9th Pangborn Sensory Science Symposium.

AMT Submits Responses to Day 120 Questions to EMA as Part of the Review Process for Glybera(R)

AMSTERDAM, November 23, 2010 – Amsterdam Molecular Therapeutics (Euronext Amsterdam: AMT), a
leader in the field of human gene therapy, today announces that it has
submitted its responses to the Day 120 questions posed by the European
Medicines Agency (EMA) as part of the review process for Glybera(R), a gene
therapy for lipoprotein lipase deficiency (LPLD). As outlined … Read this article on Gaea Times at : AMT Submits Responses to Day 120 Questions to EMA as Part of the Review Process for Glybera(R).

Intelsius Adds Two New Category A Shipping Solutions to Line of Biotherm Packaging Systems

YORK, England, November 23, 2010 – Intelsius, a global manufacturer and distributor of environmentally safe,
temperature-controlled and regulatory-compliant packaging solutions, has
added two new Category A shipping systems to its existing line of Biotherm
packaging solutions.

(Logo: photos.prnewswire.com/prnh/20101012/DE80101LOGO )
Biotherm Category A shipping systems are designed to ensure full
compliance with IATA, … Original article on : Intelsius Adds Two New Category A Shipping Solutions to Line of Biotherm Packaging Systems.

Teva Launches Prednisolone EC Tablets

CASTLEFORD, England, November 23, 2010 – We are pleased to announce the launch of a generic version of
Prednisolone enteric-coated (EC) tablets.

Prednisolone EC tablets are a generic version of Deltacortril(R) from
Alliance Pharmaceuticals Limited and are indicated in the treatment of
inflammatory and allergic conditions such as asthma, rheumatoid arthritis and
colitis.
…. Source  : Teva Launches Prednisolone EC Tablets.

New Cervical Cancer Screening Test Set to Save the Lives of Women All Over the UK

Landmark Study Confirms Accuracy of Roche's Human Papillomavirus Test for the Detection of Cervical Pre-Cancer Missed by Existing Screening Methods

BURGESS HILL, England, November 24, 2010 – The largest ever registrational study for a diagnostic product, involving
more than 47,000 women shows that the cobas(R) 4800 Human Papillomavirus
(HPV) test from Roche, is able to improve the … Read more >>.